Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: involvement of brain antioxidant and BDNF upregulating properties
Moreover, Wang et al
Because Alzheimers disease and dementia risk are closely connected to insulin resistance, vascular health, inflammation, and metabolic dysfunction, researchers are asking whether GLP-1 signaling may influence brain aging
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects
When used appropriatelymeaning clinically indicated patients taking FDA-approved formulations prescribed for them per medical guidelines while being monitored by a healthcare professionalthey have a well-characterized safety profile
Chaves Filho AJM, Cunha NL, de Souza AG, Soares MV, Juc PM, de Queiroz T, et al